Inventor · disambiguated record
Duane Demong
Also filed as: DEMONG DUANE · DEMONG DUANE E · DEMONG DUANE EUGENE
30 granted patents·10 pending applications·54 citations·filing 2005–2025
94Inventor score
Files withMERCK SHARP & DOHME18MERCK SHARP & DOHME LLC10GILBERT ERIC J2BOYCE CHRISTOPHER W1COLLETTI STEVEN L1
Top patents by PatentIndex Score
40 records- 0195US9718818B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Aug 1, 2017·25 cites·9 claims
- 0288US11312719B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME·Filed 2019·Granted Apr 26, 2022·4 cites·25 claims
- 0388US10793557B2Sting agonist compoundsMERCK SHARP & DOHME·Filed 2019·Granted Oct 6, 2020·4 cites·43 claims
- 0482US10100042B2[5,6]—fused bicyclic antidiabetic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Oct 16, 2018·3 cites·13 claims
- 0581US12263171B27-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·2 cites·20 claims
- 0676US9493440B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Nov 15, 2016·2 cites·18 claims
- 0775US8361959B2Spiro-imidazolone derivatives as glucagon receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted Jan 29, 2013·2 cites·18 claims
- 0873US9809568B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·1 cites·10 claims
- 0973US8623818B2Glucagon receptor antagonists, compositions, and methods for their useGREENLEE WILLIAM J·Filed 2009·Granted Jan 7, 2014·2 cites·12 claims
- 1072US9416126B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Aug 16, 2016·2 cites·18 claims
- 1172US8623873B2Substituted piperazines as CB1 antagonistsGILBERT ERIC J·Filed 2008·Granted Jan 7, 2014·2 cites·94 claims
- 1272US2025382300A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1371US12060357B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2022·Granted Aug 13, 2024·0 cites·28 claims
- 1471US9688654B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Jun 27, 2017·1 cites·10 claims
- 1571US9440952B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Sep 13, 2016·1 cites·19 claims
- 1669US10806724B2Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2019·Granted Oct 20, 2020·0 cites·12 claims
- 1769US2025387397A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1867US10968193B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Apr 6, 2021·1 cites·11 claims
- 1967US8735604B2Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their useGILBERT ERIC J·Filed 2010·Granted May 27, 2014·1 cites·11 claims
- 2066US9840512B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·1 cites·23 claims
- 2164US10335399B2Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jul 2, 2019·0 cites·28 claims
- 2261US12414952B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 16, 2025·0 cites·10 claims
- 2360US12466831B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 11, 2025·0 cites·14 claims
- 2459US2025171447A1Adenosine receptor antagonists, pharmaceutical compositions and their use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2558US2025059220A1Substituted benzothiophene derivatives and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2654US2024076297A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2753US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 2848US2010249144A1Substituted piperazines as cb1 antagonistsDEMONG DUANE EUGENE·Filed 2008·Application pending·0 cites
- 2946US11702430B2Aza-benzothiophene compounds as STING agonistsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 18, 2023·0 cites·21 claims
- 3043US11225471B2Antidiabetic bicyclic compoundsCOLLETTI STEVEN L·Filed 2018·Granted Jan 18, 2022·0 cites·24 claims
- 3143US2007197590A1Substituted dipiperidine ccr2 antagonistsDEMONG DUANE E·Filed 2007·Application pending·0 cites
- 3242US2006069123A1Substituted dipiperidine CCR2 antagonistsXIA MINGDE·Filed 2005·Application pending·0 cites
- 3340US9006228B2Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatmentMILLER MICHAEL·Filed 2012·Granted Apr 14, 2015·0 cites·19 claims
- 3436US10662171B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted May 26, 2020·0 cites·15 claims
- 3534US10059667B2Antidiabetic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Aug 28, 2018·0 cites·11 claims
- 3634US8633231B2Substituted imidazolones, compositions containing such compounds and methods of useDEMONG DUANE·Filed 2011·Granted Jan 21, 2014·0 cites·16 claims
- 3733US10954240B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2015·Granted Mar 23, 2021·0 cites·5 claims
- 3832US8957062B2Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatmentEDMONDSON SCOTT·Filed 2012·Granted Feb 17, 2015·0 cites·18 claims
- 3932US2013012493A1Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their useZHAO HE·Filed 2011·Application pending·0 cites
- 4031US10131651B2[7,6]-fused bicyclic antidiabetic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Nov 20, 2018·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →